Cardurion Pharmaceuticals

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases. Founded by physician-scientists with world-class expertise in cardiovascular signaling pathways, Cardurion is committed to developing a pipeline of novel treatment options to improve the lives of patients. The company's innovative approach has resulted in two groundbreaking first-in-class clinical programs: a PDE9 inhibitor targeting heart failure and the first-ever CaMKII inhibitor in clinical development targeting multiple cardiovascular indications.

Cardurion has assembled a team of physician-scientists and industry leaders with extensive experience in cardiovascular science, drug development and business development. The company has facilities in Burlington, Massachusetts and Shonan, Japan, and is dedicated to advancing novel mechanisms that yield new treatments for cardiovascular disease, which remains the greatest cause of morbidity and mortality in our society.

Cardurion Pharmaceuticals is committed to fostering a diverse and inclusive workplace that promotes equitable employment practices. They provide all employees with the support to succeed and grow, regardless of their background or identity. Their culture emphasizes collaboration, open communication, and resilience in the face of challenges. Employees at Cardurion feel respected and recognized, and they trust senior leadership's commitment to quality and investment in employee success.

Cardurion Pharmaceuticals is a clinical-stage biotechnology company dedicated to transforming the treatment of cardiovascular diseases. Driven by a team of physician-scientists with world-class expertise, Cardurion is developing novel, next-generation therapeutics to address the significant unmet needs of patients suffering from heart failure and other cardiovascular conditions. Their mission is to translate groundbreaking science in cardiovascular signaling pathways into life-changing treatments that improve patient outcomes and change the course of cardiovascular disease.

Cardurion Pharmaceuticals fosters a collaborative and inclusive culture that prioritizes patient needs and scientific excellence. They value open communication, integrity, and resilience, empowering their employees to succeed and grow regardless of background or identity. The company believes in building a team of passionate and dedicated individuals who work together to deliver groundbreaking treatments for cardiovascular diseases, seeing challenges as opportunities to innovate and improve patient lives.

Cardurion Pharmaceuticals is committed to fostering a diverse and inclusive workplace that promotes equitable employment practices. They believe their people are their greatest asset and strive to create an environment where all employees feel valued and respected, regardless of background or identity. They provide support to help employees succeed and grow, ensuring equal access to professional development and advancement opportunities.